Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope

被引:42
作者
Darbha, R
Phogat, S
Labrijn, AF
Shu, Y
Gu, YJ
Andrykovitch, M
Zhang, MY
Pantophlet, R
Martin, L
Vita, C
Burton, DR
Dimitrov, DS
Ji, XH
机构
[1] NCI Frederick, Macromol Crystallog Lab, Ft Detrick, MD 21702 USA
[2] NCI Frederick, Lab Expt & Computat Biol, Ft Detrick, MD 21702 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[5] CEA Saclay, Protein Engn & Res Dept, F-91191 Gif Sur Yvette, France
关键词
D O I
10.1021/bi035323x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human monoclonal antibody Fab X5 neutralizes a broad range of HIV-1 primary isolates. The crystal structure of X5 has been determined at 1.9 Angstrom resolution. There are two crystallographically independent Fab fragments in the asymmetric unit. The crystallographic R value for the final model is 0.22. The antibody-combining site features a long (22 amino acid residues) CDR H3 with a protruding hook-shaped motif. The X5 structure and site-directed mutagenesis data suggest that X5 amino acid residues W 100 and Y100F in the CDR H3 motif may be critical for the binding of Fab X5 to gp120. X5 bound to a complex of a CD4 mimetic and gp120 with approximately the same kinetics and affinity as to a CD4-gp120 complex, suggesting that specific interactions between CD4 and X5 are unlikely to contribute to the binding of X5 to gp120-CD4 complexes. Binding of X5 to alanine scanning mutants of gp120JR-CSF complexed with CD4 suggested a critical role of the highly conserved amino acid residues at positions 423 and 432. The X5 structure and fine mapping of its epitope may assist in the elucidation of the mechanisms of viral entry and neutralization, and the development of HIV-1 inhibitors and vaccines.
引用
收藏
页码:1410 / 1417
页数:8
相关论文
共 26 条
  • [1] [Anonymous], ACTA CRYSTALLOGR D
  • [2] Barbas C. F., 2001, PHAGE DISPLAY LAB MA
  • [3] Crystallographic refinement by simulated annealing: Methods and applications
    Brunger, AT
    Rice, LM
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 : 243 - 269
  • [4] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [5] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY
    BURTON, DR
    PYATI, J
    KODURI, R
    SHARP, SJ
    THORNTON, GB
    PARREN, PWHI
    SAWYER, LSW
    HENDRY, RM
    DUNLOP, N
    NARA, PL
    LAMACCHIA, M
    GARRATTY, E
    STIEHM, ER
    BRYSON, YJ
    CAO, YZ
    MOORE, JP
    HO, DD
    BARBAS, CF
    [J]. SCIENCE, 1994, 266 (5187) : 1024 - 1027
  • [6] Cell biology of virus entry
    Dimitrov, DS
    [J]. CELL, 2000, 101 (07) : 697 - 702
  • [7] Fusin - A place for HIV-1 and T4 cells to meet
    Dimitrov, DS
    [J]. NATURE MEDICINE, 1996, 2 (06) : 640 - 641
  • [8] Mechanisms of viral membrane fusion and its inhibition
    Eckert, DM
    Kim, PS
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 777 - 810
  • [9] An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
    Esnouf, RM
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) : 132 - +
  • [10] Electron-density map interpretation
    Jones, TA
    Kjeldgaard, M
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 : 173 - 208